Health Care & Insurance

Health chief: Indiana needs more trauma center access

January 18, 2011
Associated Press
State Health Commissioner Greg Larkin says much of Indiana lacks the access to hospital trauma centers needed to treat victims of attacks like the one in Tucson that left U.S. Rep. Gabrielle Giffords of Arizona critically injured.
More

Lilly imaging drug isn't ready for approval, FDA says

January 18, 2011
Eli Lilly and Co.’s experimental drug to help identify plaque in the brain tied to Alzheimer's disease isn't ready for approval, according to U.S. regulators.
More

Community Health plans $12M east-side medical complex

January 17, 2011
Construction is set to begin soon on Community Health Pavilion, a three-story, 55,000-square-foot medical building to be built on six acres at 7910 E. Washington St.
More

WellPoint headquarters snags $42M

January 15, 2011
Cory Schouten
Massachusetts-based Franklin Street Properties acquired the Monument Circle headquarters of insurance giant WellPoint Inc. late in 2010 for $42 million—a rich $196 per square foot—from an affiliate of locally based HDG Mansur.
More

By wide margin, Anthem still city's largest insurerRestricted Content

January 15, 2011
Scott Olson
Anthem Blue Cross and Blue Shield's share of the Indianapolis area has leveled off, even though it still insures more than half the commercial market—or three times as much as its nearest competitor.
More

Can video games be good for your health?

January 15, 2011
J.K. Wall
Local companies are embedding stealthy video messages for high school and college students.
More

LAMKIN: Health care reform is opportunity to reorganize servicesRestricted Content

January 15, 2011
Ned Lamkin
Indiana should take advantage of the opportunity to build a comprehensive exchange.
More

Endocyte prices IPO stock

January 14, 2011
J.K. Wall
The West Lafayette-based drug development firm intends to sell 6.15 million shares for $13 to $15 apiece. That would fetch $80 million to $92 million.
More

Panel says Lilly’s Solpura isn’t ready for approval

January 12, 2011
Bloomberg News
Eli Lilly and Co. failed to win an FDA advisory panel’s recommendation to introduce the first pancreatic enzyme that isn’t derived from pig parts.
More

Roche back in court as partner looks to sell to competitor

January 12, 2011
J.K. Wall
Roche Diagnostics requested a temporary restraining order against Medical Automation Systems Inc. Tuesday after receiving word the company is speeding up plans to sell itself to Roche rival Alere Inc.
More

Deal could give Lilly full diabetes deck

January 12, 2011
J.K. Wall
Eli Lilly and Co.'s diabetes partnership with Boehringer Ingelheim GmbH represents a new kind of disease-focused strategy that some consultants think is key to pharma companies’ futures.
More

Q&A: Derek Bang

January 12, 2011
J.K. Wall
Derek Bang, practice leader of health care advisory services at the Crowe Horwath accounting firm in Indianapolis, spent a week in March studying health care in the United Kingdom, especially its universal health care program. He was surprised by the “daily barrage of criticism” he heard about the National Health Service, but also found that the United Kingdom and United States face very similar issues when it comes to constraining growth in health care costs.
More

UPDATE: Analysts praise Lilly diabetes deal with Boehringer

January 11, 2011
J.K. Wall
The deal Eli Lilly and Co. announced Tuesday morning with Boehringer Ingelheim GmbH sounded a lot like a baseball trade—with five drugs and payments to be named later—but analysts and investors generally liked what they heard.
More

Lilly agrees to pay up to $1.2B for diabetes drugs

January 11, 2011
J.K. Wall
A complex deal with Boehringer Ingelheim also gives the German company rights to two experimental Lilly insulins.
More

Lilly partner moves up timetable for diabetes drug

January 11, 2011
Bloomberg News
Amylin Pharmaceuticals Inc., rebuffed twice in its bid for U.S. approval of a weekly diabetes drug, will meet its timetable and submit a heart-safety study to regulators by the end of 2011, its CEO said.
More

Bill would let Indiana pharmacies collect old meds

January 10, 2011
Associated Press
A bill authored by Republican Rep. Kevin Mahan of Hartford City would revise state law so that pharmacies could accept unused prescription drugs from customers and dispose of them securely and safely.
More

Closed dental company working to transfer patients

January 10, 2011
Associated Press
Citing cash-flow problems, Allcare Dental and Dentures shut down operations in 14 states, including Indiana, last week.
More

Lilly's Solpura may lack data to prove effectiveness

January 10, 2011
Bloomberg News
Outside advisers to the FDA will meet Jan. 12 to review whether the drug should be approved for people with pancreas insufficiency caused by cystic fibrosis, chronic pancreatitis or other conditions.
More

IndyCar deal creates series-branded insurance plan

January 5, 2011
Anthony Schoettle
Open-wheel race series signs three-year sponsorship pact with Dallas-based Global Corporate Alliance.
More

New doc lifts Community breast biz

January 5, 2011
J.K. Wall
Community Health Network wooed Dr. Robert J. Goulet Jr. to join its breast-surgery team from the Indiana University Simon Cancer Center. The move fits nicely with Community’s focus on breast-care services and the economics of health care.
More

Latest iPhone app: Baby EKG

January 5, 2011
J.K. Wall
Mobile medicine has arrived. Decatur County Memorial Hospital in Greensburg became the first hospital in Indiana to start using AirStrip OB, a patient-monitoring system that sends things like the heartbeat waves of patients directly to physicians’ iPhones, BlackBerrys or other mobile devices.
More

Lilly bumped up federal lobbying in third quarter

January 4, 2011
Associated Press
The Indianapolis-based drugmaker spent $2.1 million in the three months that ended Sept. 30, a 5-percent increase from the same quarter last year and a jump of more than 30 percent from the $1.6 million it spent in this year's second quarter.
More

Lilly, other big drugmakers shut out by FDA in 2010

January 3, 2011
 IBJ Staff and Bloomberg News
Regulators cleared 21 medicines, the fewest since 2007, for sale last year. It was the first time in a decade that Pfizer Inc., the world's largest drugmaker, as well as Lilly, Merck & Co. and Bristol-Myers Squibb Co. were shut out at the same time, according to agency records.
More

Conseco brass agree to settle 8-year-old suit for $41.5MRestricted Content

January 1, 2011
Greg Andrews
The suit accused CEO Gary Wendt, President Bill Shea, Chief Financial Officer Charles Chokel and Chief Accounting Officer Jim Adams of engaging in a “massive and systematic coverup of ... actual debts and losses through complex accounting, misleading disclosures, and irregular accounting practices.”
More

Indiana Medicaid cuts likely to be followed by more

December 30, 2010
Associated Press
The Office of Medicaid Policy and Planning has approved a series of emergency rules that it expects to save a total of $4.1 million over the next six months, but that will make up for only a small portion of the $31.4 million shortfall the agency anticipates for the fiscal year.
More
Page  << 61 62 63 64 65 66 67 68 69 70 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT